BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 23526226)

  • 1. Telomerase and telomere length in pulmonary fibrosis.
    Liu T; Ullenbruch M; Young Choi Y; Yu H; Ding L; Xaubet A; Pereda J; Feghali-Bostwick CA; Bitterman PB; Henke CA; Pardo A; Selman M; Phan SH
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):260-8. PubMed ID: 23526226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase deficiency does not alter bleomycin-induced fibrosis in mice.
    Degryse AL; Xu XC; Newman JL; Mitchell DB; Tanjore H; Polosukhin VV; Jones BR; McMahon FB; Gleaves LA; Phillips JA; Cogan JD; Blackwell TS; Lawson WE
    Exp Lung Res; 2012 Apr; 38(3):124-34. PubMed ID: 22394286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase reverse transcriptase ameliorates lung fibrosis by protecting alveolar epithelial cells against senescence.
    Liu T; Gonzalez De Los Santos F; Zhao Y; Wu Z; Rinke AE; Kim KK; Phan SH
    J Biol Chem; 2019 May; 294(22):8861-8871. PubMed ID: 31000627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging.
    Piñeiro-Hermida S; Autilio C; Martínez P; Bosch F; Pérez-Gil J; Blasco MA
    J Cell Biol; 2020 Oct; 219(10):. PubMed ID: 32777016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1.
    Estany S; Vicens-Zygmunt V; Llatjós R; Montes A; Penín R; Escobar I; Xaubet A; Santos S; Manresa F; Dorca J; Molina-Molina M
    BMC Pulm Med; 2014 Jul; 14():120. PubMed ID: 25064447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From organ to cell: Multi-level telomere length assessment in patients with idiopathic pulmonary fibrosis.
    van Batenburg AA; Kazemier KM; van Oosterhout MFM; van der Vis JJ; van Es HW; Grutters JC; Goldschmeding R; van Moorsel CHM
    PLoS One; 2020; 15(1):e0226785. PubMed ID: 31910222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KLF4 regulates TERT expression in alveolar epithelial cells in pulmonary fibrosis.
    Wang H; Xu H; Lyu W; Xu Q; Fan S; Chen H; Wang D; Chen J; Dai J
    Cell Death Dis; 2022 May; 13(5):435. PubMed ID: 35508454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
    Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
    Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
    [No Abstract]   [Full Text] [Related]  

  • 9. Telomerase gene mutations and telomere length shortening in patients with idiopathic pulmonary fibrosis in a Chinese population.
    Dai J; Cai H; Zhuang Y; Wu Y; Min H; Li J; Shi Y; Gao Q; Yi L
    Respirology; 2015 Jan; 20(1):122-8. PubMed ID: 25346280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice with Pulmonary Fibrosis Driven by Telomere Dysfunction.
    Povedano JM; Martinez P; Flores JM; Mulero F; Blasco MA
    Cell Rep; 2015 Jul; 12(2):286-99. PubMed ID: 26146081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere shortening activates TGF-β/Smads signaling in lungs and enhances both lipopolysaccharide and bleomycin-induced pulmonary fibrosis.
    Liu YY; Shi Y; Liu Y; Pan XH; Zhang KX
    Acta Pharmacol Sin; 2018 Nov; 39(11):1735-1745. PubMed ID: 29925920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of telomere related gene mutations in idiopathic pulmonary fibrosis.
    Yildirim H; Yildiz P; Coskunpinar E
    Mol Biol Rep; 2020 Oct; 47(10):7851-7860. PubMed ID: 33006015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice.
    Liu T; Chung MJ; Ullenbruch M; Yu H; Jin H; Hu B; Choi YY; Ishikawa F; Phan SH
    J Clin Invest; 2007 Dec; 117(12):3800-9. PubMed ID: 18008008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential telomerase expression in idiopathic pulmonary fibrosis and non-small cell lung cancer.
    Antoniou KM; Samara KD; Lasithiotaki I; Margaritopoulos GA; Soufla G; Lambiri I; Giannarakis I; Drositis I; Spandidos DA; Siafakas NM
    Oncol Rep; 2013 Dec; 30(6):2617-24. PubMed ID: 24067943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
    Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
    J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A concise review of telomere and telomerase-related genetic markers in fibrotic lung diseases].
    Fan YL; Ye Q
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 Dec; 38(12):952-956. PubMed ID: 33406566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
    Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
    Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.
    Ley B; Newton CA; Arnould I; Elicker BM; Henry TS; Vittinghoff E; Golden JA; Jones KD; Batra K; Torrealba J; Garcia CK; Wolters PJ
    Lancet Respir Med; 2017 Aug; 5(8):639-647. PubMed ID: 28648751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hTERT mutations associated with idiopathic pulmonary fibrosis affect telomerase activity, telomere length, and cell growth by distinct mechanisms.
    Tsang AR; Wyatt HD; Ting NS; Beattie TL
    Aging Cell; 2012 Jun; 11(3):482-90. PubMed ID: 22364217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.